360° Coverage : Discount Packages on Global Trends and Developments in Top...

1 Updates

Discount Packages on Global Trends and Developments in Top Therapeutic Classes

Apr 4 2014, 2:13am CDT | by

New York, NY, April 04, 2014 --(PR.com)-- The global biotechnology and pharmaceutical market have seen significant positive sentiments in the recent years, especially with innovation contributing...

Filed under: news

YouTube Videos


28 weeks ago

Discount Packages on Global Trends and Developments in Top Therapeutic Classes

Apr 4 2014, 2:13am CDT | by

New York, NY, April 04, 2014 --(PR.com)-- The global biotechnology and pharmaceutical market have seen significant positive sentiments in the recent years, especially with innovation contributing to the availability of a range of new treatments for diseases. With the trend continuing, the markets expect innovation and improved drugs therapies through novel target discovery and technology platforms. The market optimism is based on the continuity in the flow of innovative products, implementation of strategic decisions to improve cost efficiency, strengthen therapeutic leadership, and hedge against generic threats. The pharmaceutical markets around the globe have seen significant developments in the treatment areas with innovation contributing to crucial developments in top therapeutic classes, which have considerably improved patients pain, function, and quality of life.

In keeping with the global demand, Research on Global Markets come up with a host of premium reports on the latest developments and trends across the globe on various new age drugs and treatment options that have evolved in the top therapeutic classes. Some of the latest reports are now available in discounted packages to assist healthcare companies across geographies take more informed decisions.

Combination Offer: 6 Reports on Developments in Top Therapeutic Classes
20% discount - You save: $2,500
Original Price: $12,500 | Offer price: $10,000

Treating Refractory Hematological Malignancies: Multiple Myeloma (MM) New Treatment Options Driving In-Licensing and M&A
The report offers a detailed financial and competitive analysis of the companies leading in this field for this indication - Celgene, Amgen (post-acquisition of Onyx pharma), and MorphoSys. Key M&A activities that have taken place in this area in the last 5 years and a list of products in early /late-stages of development available for in-licensing are highlighted in the report.

Newer Oral Anti Androgens – Expanding Role in the treatment Paradigm of Prostate Cancer
The report highlights the future role of Oral Antiandrogens in treatment of Prostate Cancer including how the approval and launch of various newer treatment options like Xtandi (Enzalutamide, Astellas/Medivation), Zytiga (Abiraterone acetate, JNJ), Jevtana (Cabazitaxel, Sanofi), & Xofigo (radium Ra 223, Boehringer Ingelheim) has evolved the treatment paradigm of treating late stage prostate cancer.

Psoriasis – Plaque Psoriasis & Psoriatic Arthritis: Novel Oral drugs and Biologics to Change Future Treatment Paradigm
The report discusses novel Oral drugs and Biologics to change future treatment paradigm for Psoriasis - Plaque Psoriasis & Psoriatic Arthritis highlighting the unmet need in Psoriasis, alongwith a commercial outlook, current treatment options and treatment efficacy tools.

Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies
This comprehensive report on novel drug delivery system focuses mainly on the oral and injectable formulations of pharmaceuticals and specialty companies. Wherever possible, marketed drugs using a similar technology have been discussed as proof of validation along with the status of additional pipeline. The discussed proprietary formulation technologies includes Colal, Glide SDI, Arestat, GeoClock, GeoMatrix, FlashTab, Lock Tab, Medusa, Eligen, Oradur, EnteriCare and Saber.

Emergence Of Biogenerics Era In Japan: It's time to welcome antibody Biosimilars of Foreign Origins Soon
The report highlights the Investment Thesis in the space – with details of opening opportunities, Japanese companies and the Japan Biosimilar Pipeline- Expected Competition. The details of intensified competition in the Biosimilar space, alongwith the evolving landscape of the Biogenerics market in Japan with the country-specific drivers and hurdles are available in this report.

New Avatars of Microbes Super Bugs a Growing Threat Worldwide
The report provides details on the evolution and global dissemination of AMR, the unmet need in the critical setting esp. Gram Negative infections and CRE alongwith pipeline of novel targets being used to develop new drugs to treat infections and resistance. Pipeline of select drugs in mid and late clinical stage of development, alarming facts about AMR and the steps being taken by the regulatory authorities are focus points in this report. The report further discusses the role of diagnostics and preventive approach and the trends in pathogens and resistance in developing markets.

Contact Information:
Research on Global Markets
Gaurav Kumar
+91 22 4098 7690
Contact via Email

Read the full story here: http://www.pr.com/press-release/550859

Press Release Distributed by PR.com


Don't miss ...


<a href="/latest_stories/all/all/29" rel="author">PR.com</a>
PR.com press-releases.


blog comments powered by Disqus

Latest stories

China stocks open higher
Beijing, Oct 20 (IANS) Chinese stocks opened higher Monday with the benchmark Shanghai Composite Index opening at 2,346.05 points, up 4.87 points, or 0.21 percent.
US defence department to create medical team for Ebola
Washington, Oct 20 (IANS) The US Department of Defense said Sunday the military is creating a 30-member team which will be tasked with providing emergency assistance in case of Ebola virus infection in the country.
Israel's Tamar gas field to sell gas to Egypt
Jerusalem, Oct 20 (IANS) Israel's Tamar gas field announced Sunday they have signed a bid to sell at least five billion cubic meters of natural gas over three years to private consumers in Egypt.
Liberian president calls for global support to fight Ebola
Monrovia, Oct 20 (IANS) Liberian President Ellen Johnson Sirleaf Sunday called on the international communities to join the country to fight the Ebola virus disease.

Latest from the Network

Bush shoe-tossing painting hits record at Doha auction
Doha, Oct 15 (IANS/EFE) A controversial painting by Iranian artist Mahmud Obaidi, depicting an Iraqi journalist throwing shoe in 2008 at then US president George W. Bush, was sold for $62,500 at a Sotheby's auction in...
Read more on Celebrity Balla
US offers $45 mn bounty for eight terror leaders
Washington, Oct 15 (IANS) The US said Tuesday it is offering rewards totalling up to 45 million dollars for information on eight key leaders of the Al Qaeda in the Arabian Peninsula (AQAP) terrorist organisation. The...
Read more on Politics Balla
UNSC extends peacekeeping mission's term in Abyei
United Nations, Oct 15 (IANS) The UN Security Council (UNSC) has renewed the mandate of the UN peacekeeping mission in the Abyei border region between Sudan and South Sudan. In an unanimously adopted resolution, the...
Read more on Politics Balla
Ebola cases in West Africa could reach 10,000 per week: WHO
Geneva, Oct 15 (IANS) The World Health Organisation (WHO) has warned that the Ebola epidemic in West Africa could reach 5,000 to 10,000 cases per week by the first week of December. "Quite frankly, ladies and...
Read more on Business Balla
Turkey, Singapore sign strategic partnership agreement
Ankara, Oct 15 (IANS) Turkey and Singapore have signed a strategic partnership agreement to boost economic, political and cultural cooperation, as well as security collaboration, during the official visit of...
Read more on Politics Balla
Christina Aguilera is returning to 'The Voice' USA
Christina Aguilera will return to 'The Voice' USA next year. The 'Your Body' hitmaker, who previously shared a rotating spot on the judging panel with Shakira, has been replaced by Gwen Stefani this season as she is...
Read more on Celebrity Balla
Kesha's music producer hits back
Kesha is being countersued by her record company boss, Dr. Luke. The 41-year-old music producer, who runs Kemosabe Records, claims the 27-year-old 'Tik Tok' singer is a liar and is trying to extort him after she accused...
Read more on Celebrity Balla
Jason Derulo won't get back together with Jordin Sparks
Jason Derulo insists his split from Jordin Sparks is permanent. The 'Talk Dirty' hitmaker, who recently ended his relationship with the 'No Air' singer after three years of dating, has ruled out getting back together...
Read more on Celebrity Balla
Josh Groban feels 'very lucky' to be dating Kat Dennings
Josh Groban feels ''very lucky'' to be dating Kat Dennings. The 'Brave' hitmaker was very nervous before singing in front of the '2 Broke Girls' actress for the first time at the Carousel of Hope Ball in Beverly Hills,...
Read more on Celebrity Balla
Australian Richard Flanagan wins 2014 Man Booker prize
London, Oct 15 (IANS) The first Man Booker prize to allow American nominees was Tuesday night won by an Australian, with Richard Flanagan triumphing for a novel of love and war that tells the harrowing stories of...
Read more on Celebrity Balla